Zydus Lifesciences Strengthens US Oncology Footprint with $166 Million Acquisition of Assertio
In a strategic move to deepen its presence in the US specialty and oncology markets, Zydus Lifesciences has announced the acquisition of Assertio Holdings for $166.4 million. This acquisition marks a significant expansion for Zydus, providing the [...]
